• Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Products
/
Back to catalog
Home / Products / Cefuroxime + Water for injection

Cefuroxime + Water for injection

1 vial and 1 ampoule
Group of action
Antimicrobial agents for systemic use
Active ingredient
Cefuroxime
Dosage form
Powder for solution for injections
ATC code
J01D С02
RX/OTC
RX
Marketing authorisation no.
UA/15365/01/01
Download instruction leaflet in PDF

General properties

Pharmacotherapeutic group

Antibacterials for systemic use. Second-generation cephalosporins. 

Indications

Treatment of infections caused by cefuroxime sensitive bacteria, or treatment of infections before the infecting organism has been identified. Respiratory tract infections: acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections;  Ear, nose and throat infections: sinusitis, tonsillitis, pharyngitis; Urinary tract infections: acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria; Soft-tissue infections: cellulitis, erysipelas and wound infections; Bone and joint infections: osteomyelitis and septic arthritis; Obstetric and gynaecological infections: pelvic inflammatory diseases; Gonorrhoea particularly when penicillin is unsuitable. Other infections including septicaemia and meningitis. Prophylaxis against post-operative chest, abdominal, pelvic infections, after vascular, cardiac and orthopaedic infection. Usually Cefuroxime will be effective alone, but when appropriate it may be used in combination with an aminoglycoside antibiotic, or in conjunction with metronidazole (orally or by suppository or injection). In situations where mixed aerobic and anaerobic infections are encountered or suspected (e.g. peritonitis, aspiration pneumonia, abscesses in the lung, pelvis and brain), or are likely to occur (e.g. in association with colorectal or gynaecological surgery) it is appropriate to administer Cefuroxime in combination with metronidazole. Where appropriate cefuroxime is effective when used prior to oral therapy with cefuroxime axetil in the treatment of pneumonia and acute exacerbations of chronic bronchitis.

Contraindications

Hypersensitivity to cefuroxime. Hypersensitivity to cephalosporin antibiotics. A history of severe hypersensitivity (e.g. anaphylactic reactions) to other beta-lactam antibiotics (penicillins, monobactams and carbapenems).

Pharmaceutical characteristics

Basic physical and chemical properties

A white to off-white powder.

Shelf life
2 years.
Storage conditions

Store in original package at temperature not exceeding 25 °С. Keep out of reach of children. The reconstituted solution should be stored at 2-8 °C for no longer than 48 hours if refrigerated and for five hours if kept below 25 °C.

By prescription.
Manufacturer
JSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
Back to catalog
  • About company
    • Managing company “Lekhim”
    • Manufacturing site “Lekhim-Kharkiv”
    • Manufacturing site “Technolog”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • News/Events
  • Products
    • Browse by group of action
    • Browse alphabetically
    • Browse by active ingredient
  • Export
    • Foreign economic activity
  • Contact information
Поиск по сайту
Designed in
© 2021. Лекхим.
  • Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Поиск по сайту
Поиск по сайту